Prion Protein Fragment 106-126 Induces a p38 MAP Kinase-Dependent Apoptosis in SH-SY5Y Neuroblastoma Cells Independently from the Amyloid Fibril Formation

Annals of the New York Academy of Sciences

Volumn 1010, Issue , 2003, Pages 610-622

  Corsaro, A ^a   Thellung, S ^a   Villa, V ^a   Rossi Principe, D ^b   Paludi, D ^b   Arena, S ^a   Millo, E ^a   Schettini, D ^a,c   Damonte, G ^a   Aceto, A ^b   Schettini, G ^a,c   Florio, T ^a,c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Amyloid aggregation; Apoptosis; Caspases; p38 MAP kinase; Prion protein

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALANINE; AMYLOID; APOPTOSIS INDUCING FACTOR; CASPASE 3; GLYCINE; GLYCOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PEPTIDE; PRION PROTEIN;

ANIMAL; APOPTOSIS; ASTROCYTOSIS; BRAIN SPONGIOSIS; CANCER CELL CULTURE; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DEGENERATIVE DISEASE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NEUROTOXICITY; PRION DISEASE; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN STRUCTURE; VASCULAR AMYLOIDOSIS; WESTERN BLOTTING;

ANIMALIA;

EID: 10744228678     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1299.114     Document Type: Conference Paper

References (37)

1. PRUSINER, S.B. 1998. Prions. Proc. Natl. Acad. Sci. USA 95: 13363-13383.
2. STEFANIS, L., R.E. BURKE & L.A. GREEN. 1997. Apoptosis in neurodegenerative disorders. Curr. Opin. Neurol. 10: 299-305.
3. FORLONI, G., N. ANGERETTI, R. CHIESA, et al. 1993. Neurotoxicity of a prion protein fragment. Nature 362: 543-546.
4. TAGLIAVINI, F., F. PRELLI, L. VERGA, et al. 1993. Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc. Natl. Acad. Sci. USA 90: 9678-9682.
5. DE GIOIA, L., C. SELVAGGINI, E. GHIBAUDI, et al. 1994. Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologues to residues 106-126 of the prion protein. J. Biol. Chem. 269: 7859-7862.
6. SELVAGGINI, C., L. DE GIOIA, L. CANTÙ, et al. 1993. Molecular characteristics of a protease resistant amyloidogenic and neurotoxic peptide homologous to residue 106-126 of the prion protein. Biochem. Biophys. Res. Commun. 194: 1380-1386.
7. JOBLING, M.F., L.R. STEWART, A.R. WHITE, et al. 1999. The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126. J. Neurochem. 73: 1557-1565.
8. THELLUNG, S., T. FLORIO, V. VILLA, et al. 2000. Apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in rat cerebellar granule cells treated with the prion protein fragment 106-126. Neurobiol. Dis. 7: 299-309.
9. THELLUNG, S., T. FLORIO, A. CORSARO, et al. 2000. Intracellular mechanisms mediating the neuronal death and astrogliosis induced by the prion protein fragment 106-126. Int. J. Dev. Neurosci. 18: 481-492.
10. THELLUNG, S., V. VILLA, A. CORSARO, et al. 2002. p38 MAP kinase mediates the cell death induced by PrP106-126 in the SH-SY5Y neuroblastoma cells. Neurobiol. Dis. 9: 69-81.
11. FLORIO, T., M. GRIMALDI, A. SCORZIELLO, et al. 1996. Intracellular calcium rise through L-type calcium channels, as molecular mechanism for prion protein fragment 106-126-induced astroglial proliferation. Biochem. Biophys. Res. Commun. 228: 397-405.
12. HENGARTNER, M.O. 2000. The biochemistry of apoptosis. Science 407: 770-776.
13. GRUTTER, M.G. 2000. Caspases: key players in programmed cell death. Curr. Opin. Struct. Biol. 10: 649-655.
14. Mielke, K. & T. Herdegen. 2000. JNK and p38 stress kinases-degenerative effectors of signal-transduction-cascades in the nervous system. Prog. Neurobiol. 6: 45-60.
15. PAHLMAN, S., J.C. HOEHNER, E. NANBERG, et al. 1995. Differentiation and survival influences of growth factors in human neuroblastoma. Eur. J. Cancer. 31A: 453-458.
16. BUCCIANTINI, M., E. GIANNONI, F. CHITI, et al. 2002. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416: 507-511.
17. WELLINGS, D.A. & E. ATHERTON. 1997. Standard Fmoc protocols. Methods Enzymol. 289: 44-67.
18. STEFANIS, L., D.S. PARK, C. YAN, et al. 1996. Induction of CPP32-like activity in PC12 cells by withdrawal of trophic support. J. Biol. Chem. 29: 30663-30671.
19. KLUNK, W.E., J.W. PETTEGREW & D.J. ABRAHAM. 1989. Quantitative evaluation of Congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. J. Histochem. Cytochem. 37: 1273-1281.
20. GARCIA-CALVO, M., E.P. PETERSON, B. LEITING, et al. 1998. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem. 273: 32608-32613.
21. KAWASAKI, H., T. MOROOKA, S. SHIMOHAMA, et al. 1997. Activation and involvement of p38 mitogen-activated protein kinases in glutamate-induced apoptosis in rat cerebellar granule cells. J. Biol. Chem. 272: 18518-18521.
22. KUMMER, J.L., P.K. RAO & K.A. HEINDENREICH. 1997. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J. Biol. Chem. 272: 20490-20494.
23. GHATAN, S., S. LARNER, Y. KINOSHITA, et al. 2000. p38 MAP kinase mediates Bax translocation in nitric oxide-induced apoptosis in neurons. J. Cell. Biol. 150: 335-347.
24. KURATA, S. 2000. Selective activation of p38 MAPK cascade and mitotic arrest caused by low level oxidative stress. J. Biol. Chem. 275: 23413-23416.
25. Ono, K. & J. Han. 2000. The p38 signal transduction pathway. Activation and function. Cell Signal. 12: 1-13.
26. LI, Y.P., A.F. BUSHNELL, C.M. LEE, et al. 1996. Beta-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells. Brain Res. 738: 196-204.
27. MORIYA, R., T. UEHARA & Y. NOMURA. 2000. Mechanism of nitric oxide-induced apoptosis in human neuroblastoma SH-SY5Y. FEBS Lett. 484: 253-260.
28. HAN, J., J.D. LEE, L. BIBBS & R.J. ULEVITCH. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265: 808-811.
29. XIA, Z., M. DICKENS, J. RAINGEAUD, et al. 1995. Opposite effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331.
30. ZHANG, H., X. SHI, M. HAMPONG, et al. 2001. Stress-induced inhibition of ERK1 and ERK2 by direct interaction with p38 MAP kinase. J. Biol. Chem. 276: 6905-6908.
31. BROWN, D.R. 2000. Prion protein peptides: optimal toxicity and peptide blockade of toxicity. Mol. Cell. Neurosci. 15: 66-78.
32. WONG, B.S., T. PAN, T. LIU, et al. 2000. Prion disease: a loss of antioxidants function? Biochem. Biophys. Res. Comm. 28: 249-252.
33. KRISTENSSON, K., B. FEUERSTEIN, A. TARABULOS, et al. 1993. Scrapie prions alter receptor-mediated calcium responses in cultured cells. Neurology 43: 2335-2341.
34. O'DONOVAN, C., D. TOBIN & T.G. COTTER. 2001. Prion protein fragment PrP106-126 induces apoptosis via mitochondrial disruption in human neuronal SH-SY5Y cells. J. Biol. Chem. 276: 43516-43523.
35. JUNN, E. & M.M. MOURADIAN. 2001. Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases. J. Neurochem. 78: 374-383.
36. FORLONI, G., O. BUGIANI, F. TAGLIAVINI & M. SALMONA. 1996. Apoptosis-mediated neurotoxicity induced by beta-amyloid and PrP fragments. Mol. Chem. Neuropathol. 28: 163-171.
37. BROWN, D.R. 2000. PrPSc-like prion protein peptide inhibits the function of cellular prion protein. Biochem. J. 352: 511-518.